0000000000109570
AUTHOR
Jonathan Edgeworth
Additional file 5: Table S4. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Final risk models at admission, 24Â h and end of calendar day 3. (DOC 44 kb)
Additional file 6: Figure S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Area under the operating curve for clinical decision rules. (DOC 110 kb)
Additional file 5: Table S4. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Final risk models at admission, 24Â h and end of calendar day 3. (DOC 44 kb)
Additional file 1: Table S1. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Site of Candida invasive fungal disease (Nâ =â 359). (DOC 31 kb)
Additional file 3: Table S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Therapies received, fungal colonisation, mortality and length of stay by invasive fungal disease subgroup. (DOC 61 kb)
Additional file 4: Table S3. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Description of patients included at each time point in each of the development and validation samples. (DOC 37 kb)
Additional file 4: Table S3. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Description of patients included at each time point in each of the development and validation samples. (DOC 37 kb)
Additional file 3: Table S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Therapies received, fungal colonisation, mortality and length of stay by invasive fungal disease subgroup. (DOC 61 kb)
Additional file 2: Figure S1. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Timing of Candida invasive fungal disease relative to critical care unit admission (Nâ =â 359). (DOC 27 kb)
Additional file 6: Figure S2. of Predicting invasive fungal disease due to Candida species in non-neutropenic, critically ill, adult patients in United Kingdom critical care units
Area under the operating curve for clinical decision rules. (DOC 110 kb)